Position in LLY
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$5,417,825
+$2,454,327 QoQ
Shares Held
4,517
+40.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#1,655
of 4,605 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RDA Financial Network holds $10,624,897 across 8 Drug Manufacturers - General names. LLY ranks #1 (51.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,517 | $5,417,825 | |
| 2 | PFE |
Pfizer Inc
|
69,539 | $1,674,499 | |
| 3 | JNJ |
Johnson & Johnson
|
5,338 | $1,355,691 | |
| 4 | ABBV |
AbbVie Inc.
|
3,122 | $785,620 | |
| 5 | BIIB |
Biogen Inc.
|
3,000 | $648,180 | |
| 6 | AMGN |
Amgen Inc
|
836 | $302,732 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,857 | $234,613 | |
| 8 | AZN |
Astrazeneca PLC
|
1,085 | $205,737 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,417,825 | 4,517 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $2,963,498 | 3,222 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $3,486,262 | 3,244 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $2,483,565 | 3,255 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $2,435,251 | 3,124 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $2,608,223 | 3,158 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,169,320 | 2,810 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,838,778 | 4,333 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,952,889 | 4,366 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $3,383,348 | 4,349 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $2,346,253 | 4,025 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,164,633 | 4,030 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,046,159 | 4,363 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,548,824 | 4,510 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $1,548,966 | 4,234 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $1,039,893 | 3,216 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $1,002,194 | 3,091 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,023,772 | 3,575 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $940,529 | 3,405 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $695,460 | 3,010 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $661,017 | 2,880 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $481,248 | 2,576 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $403,696 | 2,391 | Shares | Sole | 2021-02-05 | |
| 2020-06-30 | $206,702 | 1,259 | Shares | Sole | 2020-07-14 | |
| No filing history on record for this holder in this stock. | ||||||